About Unite Genomics
Unite Genomics is a private company based in San Mateo, California. It has reported $7,783,404 raised in two offerings on Form D since December 2018. Its chief executive is Taner Dagdelen.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 11, 2023 | Nov 21, 2023 | $2,000,905fully sold | 4 | $500K | EquityRule 506(b) | Form D ↗ |
| Nov 21, 2018 | Dec 6, 2018 | $5,782,499of $6.1M target | 9 | $642K | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, two offerings | $7,783,404 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Unite Genomics's Form D filed Nov 21, 2023.
TD
Taner Dagdelen
CEO and director
AJ
Anthony Joseph
Executive officer and director
Earlier filings also listed Pete Sonsini (director, last listed Dec 2018).